• Explore /
  • Poster
  • / A phase IB study of the combination of selumetinib (AZD6244; ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC).

A phase IB study of the combination of selumetinib (AZD6244; ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC).

Abstract Poster

Authors

null

Anuradha Krishnamurthy

University of Colorado, Aurora, CO

Anuradha Krishnamurthy , A. Dasari , Albert C. Lockhart , Mark N. Stein , Hanna Kelly Sanoff , James J. Lee , Aaron Richard Hansen , Tanios S. Bekaii-Saab , Usha Malhotra , Sarah Rippke , Sarah Lindsey Davis , Wells A. Messersmith , James C. Yao , Funda Meric-Bernstam , S. Gail Eckhardt , Christopher Hanyoung Lieu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Clinical Trial Registration Number

NCT02188264

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 609)

DOI

10.1200/JCO.2017.35.4_suppl.609

Abstract #

609

Poster Bd #

E5

Abstract Disclosures

Similar Posters

First Author: Anuradha Krishnamurthy

First Author: Samuel A. Jacobs

First Author: Rebecca Suk Heist

First Author: Howard Hochster